Sarcoidosis HLA class II genotyping distinguishes differences of clinical phenotype across ethnic groups

Human Molecular Genetics

Volumn 19, Issue 20, 2010, Pages 4100-4111

  Sato, Hiroe ^a   Woodhead, Felix A ^a   Ahmad, Tariq ^b   Grutters, Jan C ^c   Spagnolo, Paolo ^a,d   van den Bosch, Jules M M ^c   Maier, Lisa A ^e   Newman, Lee S ^f,g   Nagai, Sonoko ^h   Izumi, Takateru ^h   Wells, Athol U ^a   du Bois, Roland M ^a   Welsh, Kenneth I ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b PENINSULA MEDICAL SCHOOL   (United Kingdom)

^c ST ANTONIUS HOSPITAL   (Netherlands)

^d UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^e DEPARTMENT OF MEDICINE   (United States)

^f Global Health and Health Disparities   (United States)

^g UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^h Central Clinic in Kyoto   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; GENOMIC DNA; HLA ANTIGEN CLASS 2;

ARTICLE; CAUCASIAN; CLINICAL EVALUATION; CONTROLLED STUDY; DNA EXTRACTION; ERYTHEMA NODOSUM; ETHNIC GROUP; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HAPLOTYPE; HUMAN; HYPOTHESIS; JAPANESE; LUNG SARCOIDOSIS; MAJOR CLINICAL STUDY; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SARCOIDOSIS; UVEITIS;

ALLELES; ETHNIC GROUPS; GENE FREQUENCY; GENES, MHC CLASS II; GENETIC ASSOCIATION STUDIES; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; GREAT BRITAIN; HAPLOTYPES; HLA ANTIGENS; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; JAPAN; NETHERLANDS; PHENOTYPE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RISK FACTORS; SARCOIDOSIS; SARCOIDOSIS, PULMONARY; UVEITIS;

EID: 77957743735     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddq325     Document Type: Article

References (45)

1. Hillerdal, G., Nou, E., Osterman, K. and Schmekel, B. (1984) Sarcoidosis: epidemiology and prognosis. A 15-year European study. Am. Rev. Respir. Dis., 130, 29-32.
2. Costabel, U. and Hunninghake, G.W. (1999) ATS/ERS/WASOG statement on sarcoidosis. Sarcoidosis Statement Committee. American Thoracic Society. European Respiratory Society. World Association for Sarcoidosis and Other Granulomatous Disorders. Eur. Respir. J., 14, 735-737.
3. Newman, L.S., Rose, C.S. and Maier, L.A. (1997) Sarcoidosis. N. Engl. J. Med., 336, 1224-1234.
4. McGrath, D.S., Daniil, Z., Foley, P., du Bois, J.L., Lympany, P.A., Cullinan, P. and du Bois, R.M. (2000) Epidemiology of familial sarcoidosis in the UK. Thorax, 55, 751-754.
5. Schurmann, M., Lympany, P.A., Reichel, P., Muller-Myhsok, B., Wurm, K., Schlaak, M., Muller-Quernheim, J., du Bois, R.M. and Schwinger, E. (2000) Familial sarcoidosis is linked to the major histocompatibility complex region. Am. J. Respir. Crit. Care. Med., 162, 861-864.
6. Amicosante, M., Sanarico, N., Berretta, F., Arroyo, J., Lombardi, G., Lechler, R., Colizzi, V. and Saltini, C. (2001) Beryllium binding to HLA-DP molecule carrying the marker of susceptibility to berylliosis glutamate beta 69. Hum. Immunol., 62, 686-693.
7. Amicosante, M., Berretta, F., Rossman, M., Butler, R.H., Rogliani, P., Berg-Loonen, E. and Saltini, C. (2005) Identification of HLA-DRPhebeta47 as the susceptibility marker of hypersensitivity to beryllium in individuals lacking the berylliosis-associated supratypic marker HLA-DPGlubeta69. Respir. Res., 6, 94.
8. Maier, L.A., McGrath, D.S., Sato, H., Lympany, P., Welsh, K., du, B.R., Silveira, L., Fontenot, A.P., Sawyer, R.T., Wilcox, E. and Newman, L.S. (2003) Influence of MHC class II in susceptibility to beryllium sensitization and chronic beryllium disease. J. Immunol., 171, 6910-6918.
9. McCanlies, E.C., Ensey, J.S., Schuler, C.R., Kreiss, K. and Weston, A. (2004) The association between HLA-DPB1Glu69 and chronic beryllium disease and beryllium sensitization. Am. J. Ind. Med., 46, 95-103.
10. Rossman, M.D., Stubbs, J., Lee, C.W., Argyris, E., Magira, E. and Monos, D. (2002) Human leukocyte antigen Class II amino acid epitopes: susceptibility and progression markers for beryllium hypersensitivity. Am. J. Respir. Crit. Care Med., 165, 788-794.
11. Saltini, C., Richeldi, L., Losi, M., Amicosante, M., Voorter, C., Berg-Loonen, E., Dweik, R.A., Wiedemann, H.P., Deubner, D.C. and Tinelli, C. (2001) Major histocompatibility locus genetic markers of beryllium sensitization and disease. Eur. Respir. J., 18, 677-684.
12. Berlin, M., Fogdell-Hahn, A., Olerup, O., Eklund, A. and Grunewald, J. (1997) HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis. Am. J. Respir. Crit. Care Med., 156, 1601-1605.
13. Foley, P.J., McGrath, D.S., Puscinska, E., Petrek, M., Kolek, V., Drabek, J., Lympany, P.A., Pantelidis, P., Welsh, K.I., Zielinski, J. and du Bois, R.M. (2001) Human leukocyte antigen-DRB1 position 11 residues are a common protective marker for sarcoidosis. Am. J. Respir. Cell Mol. Biol., 25, 272-277.
14. Iannuzzi, M.C., Maliarik, M.J., Poisson, L.M. and Rybicki, B.A. (2003) Sarcoidosis susceptibility and resistance HLA-DQB1 alleles in African Americans. Am. J. Respir. Crit. Care Med., 167, 1225-1231.
15. Ishihara, M., Inoko, H., Suzuki, K., Ono, H., Hiraga, Y., Ando, H., Naruse, T., Ishida, T. and Ohno, S. (1996) HLA class II genotyping of sarcoidosis patients in Hokkaido by PCR-RFLP. Jpn J. Ophthalmol., 40, 540-543.
16. Ishihara, M., Ishida, T., Inoko, H., Ando, H., Naruse, T., Nose, Y. and Ohno, S. (1996) HLA serological and class II genotyping in sarcoidosis patients in Japan. Jpn. J. Ophthalmol., 40, 86-94.
17. Martinetti, M., Tinelli, C., Kolek, V., Cuccia, M., Salvaneschi, L., Pasturenzi, L., Semenzato, G., Cipriani, A., Bartova, A. and Luisetti, M. (1995) 'The sarcoidosis map': a joint survey of clinical and immunogenetic findings in two European countries. Am. J. Respir. Crit. Care Med., 152, 557-564.
18. Mrazek, F., Holla, L.I., Hutyrova, B., Znojil, V., Vasku, A., Kolek, V., Welsh, K.I., Vacha, J., du Bois, R.M. and Petrek, M. (2005) Association of tumour necrosis factor-alpha, lymphotoxin-alpha and HLA-DRB1 gene polymorphisms with Lofgren's syndrome in Czech patients with sarcoidosis. Tissue Antigens, 65, 163-171.
19. *1101: a significant risk factor for sarcoidosis in blacks and whites. Am. J. Hum. Genet., 73, 720-735.
20. Rutherford, R.M., Brutsche, M.H., Kearns, M., Bourke, M., Stevens, F. and Gilmartin, J.J. (2004) HLA-DR2 predicts susceptibility and disease chronicity in Irish sarcoidosis patients. Sarcoidosis Vasc. Diffuse Lung Dis., 21, 191-198.
21. *0201: a marker for good prognosis in British and Dutch patients with sarcoidosis. Am. J. Respir. Cell Mol. Biol., 27, 406-412.
22. Sharma, S.K., Balamurugan, A., Pandey, R.M., Saha, P.K. and Mehra, N.K. (2003) Human leukocyte antigen-DR alleles influence the clinical course of pulmonary sarcoidosis in Asian Indians. Am. J. Respir. Cell Mol. Biol., 29, 225-231.
23. Yamaguchi, E. and Kawakami, Y. (1994) Analysis of HLA antigen in Japanese patients with sarcoidosis. Nippon Rinsho, 52, 1443-1448.
24. Kreider, M.E., Christie, J.D., Thompson, B., Newman, L., Rose, C., Barnard, J., Bresnitz, E., Judson, M.A., Lackland, D.T. and Rossman, M.D. (2005) Relationship of environmental exposures to the clinical phenotype of sarcoidosis. Chest, 128, 207-215.
25. Newman, L.S., Rose, C.S., Bresnitz, E.A., Rossman, M.D., Barnard, J., Frederick, M., Terrin, M.L., Weinberger, S.E., Moller, D.R., McLennan, G. et al. (2004) A case control etiologic study of sarcoidosis: environmental and occupational risk factors. Am. J. Respir. Crit. Care Med., 170, 1324-1330.
26. Spagnolo, P., Renzoni, E.A., Wells, A.U., Sato, H., Grutters, J.C., Sestini, P., Abdallah, A., Gramiccioni, E., Ruven, H.J., du Bois, R.M. and Welsh, K.I. (2003) C-C chemokine receptor 2 and sarcoidosis: association with Lofgren's syndrome. Am. J. Respir. Crit. Care Med., 168, 1162-1166.
27. Kanterakis, S., Magira, E., Rosenman, K.D., Rossman, M., Talsania, K. and Monos, D.S. (2008) SKDM human leukocyte antigen (HLA) tool: a comprehensive HLA and disease associations analysis software. Hum. Immunol., 69, 522-525.
28. Spagnolo, P., Sato, H., Grutters, J.C., Renzoni, E.A., Marshall, S.E., Ruven, H.J., Wells, A.U., Tzouvelekis, A., van Moorsel, C.H., Van Den Bosch, J.M. et al. (2007) Analysis of BTNL2 genetic polymorphisms in British and Dutch patients with sarcoidosis. Tissue Antigens, 70, 219-227.
29. Ahmad, T., Neville, M., Marshall, S.E., Armuzzi, A., Mulcahy-Hawes, K., Crawshaw, J., Sato, H., Ling, K.L., Barnardo, M., Goldthorpe, S. et al. (2003) Haplotype-specific linkage disequilibrium patterns define the genetic topography of the human MHC. Hum. Mol. Genet., 12, 647-656.
30. *12 and their respective DRB3 specificities in clinical variants of sarcoidosis. Tissue Antigens, 57, 87-90.
31. Grunewald, J., Eklund, A. and Olerup, O. (2004) Human leukocyte antigen class I alleles and the disease course in sarcoidosis patients. Am. J. Respir. Crit. Care Med., 169, 696-702.
32. *0601 is primarily associated with the susceptibility to cardiac sarcoidosis. Tissue Antigens, 56, 52-57.
33. Saito, S., Ota, S., Yamada, E., Inoko, H. and Ota, M. (2000) Allele frequencies and haplotypic associations defined by allelic DNA typing at HLA class I and class II loci in the Japanese population. Tissue Antigens, 56, 522-529.
34. Carrington, C.V., Kondeatis, E., Ramdath, D.D., Norman, P.J., Vaughan, R.W. and Stephens, H.A. (2002) A comparison of HLA-DR and-DQ allele and haplotype frequencies in Trinidadian populations of African, South Asian, and mixed ancestry. Hum. Immunol., 63, 1045-1054.
35. *1101. J. Clin. Immunol., 30, 157-166.
36. Voorter, C.E., Amicosante, M., Berretta, F., Groeneveld, L., Drent, M. and van den Berg-Loonen, E.M. (2007) HLA class II amino acid epitopes as susceptibility markers of sarcoidosis. Tissue Antigens, 70, 18-27.
37. Karp, D.R., Marthandan, N., Marsh, S.G., Ahn, C., Arnett, F.C., Deluca, D.S., Diehl, A.D., Dunivin, R., Eilbeck, K., Feolo, M. et al. (2010) Novel sequence feature variant type analysis of the HLA genetic association in systemic sclerosis. Hum. Mol. Genet., 19, 707-719.
38. Grunewald, J., Wahlstrom, J., Berlin, M., Wigzell, H., Eklund, A. and Olerup, O. (2002) Lung restricted T cell receptor AV2S3+ CD4+ T cell expansions in sarcoidosis patients with a shared HLA-DRbeta chain conformation. Thorax, 57, 348-352.
39. Valentonyte, R., Hampe, J., Huse, K., Rosenstiel, P., Albrecht, M., Stenzel, A., Nagy, M., Gaede, K.I., Franke, A., Haesler, R. et al. (2005) Sarcoidosis is associated with a truncating splice site mutation in BTNL2. Nat. Genet., 37, 357-364.
40. Grutters, J.C., Sato, H., Pantelidis, P., Lagan, A.L., McGrath, D.S., Lammers, J.W., Van Den Bosch, J.M., Wells, A.U., du Bois, R.M. and Welsh, K.I. (2002) Increased frequency of the uncommon tumor necrosis factor 2857T allele in British and Dutch patients with sarcoidosis. Am. J. Respir. Crit. Care Med., 165, 1119-1124.
41. Grutters, J.C., Sato, H., Pantelidis, P., Ruven, H.J., McGrath, D.S., Wells, A.U., Van Den Bosch, J.M., Welsh, K.I. and du Bois, R.M. (2003) Analysis of IL6 and IL1A gene polymorphisms in UK and Dutch patients with sarcoidosis. Sarcoidosis Vasc. Diffuse Lung Dis., 20, 20-27.
42. Spagnolo, P., Renzoni, E.A., Wells, A.U., Copley, S.J., Desai, S.R., Sato, H., Grutters, J.C., Abdallah, A., Taegtmeyer, A., du Bois, R.M. and Welsh, K.I. (2005) C-C chemokine receptor 5 gene variants in relation to lung disease in sarcoidosis. Am. J. Respir. Crit. Care Med., 172, 721-728.
43. Bunce, M., O'Neill, C.M., Barnardo, M.C., Krausa, P., Browning, M.J., Morris, P.J. and Welsh, K.I. (1995) Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens, 46, 355-367.
44. Welsh, K. and Bunce, M. (1999) Molecular typing for the MHC with PCR-SSP. Rev. Immunogenet., 1, 157-176.
45. Sato, H., Nagai, S., du Bois, R.M., Handa, T., Suginoshita, Y., Ohta, K., Welsh, K.I. and Izumi, T. (2007) HLA-DQB1 0602 allele is associated with splenomegaly in Japanese sarcoidosis. J. Intern. Med., 262, 449-457.